Skip to main content
Midas Edge

Camp4 Therapeutics Corp

For the period ended Dec 31, 2025. Filed Mar 5, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 5, 2026

CAMP$4.69+15.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

TABLE OF CONTENTS

Page
Part I3
Item 1. Business7
Item 1A. Risk Factors35
Item 1B. Unresolved Staff Comments91
Item 1C. Cybersecurity91
Item 2. Properties92
Item 3. Legal Proceedings92
Item 4. Mine Safety Disclosures92
Part II93
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities93
Item 6. Reserved94
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations94
Item 7A. Quantitative and Qualitative Disclosures About Market Risk106
Item 8. Financial Statements107
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures136
Item 9A. Controls and Procedures136
Item 9B. Other Information137
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections137
Part III
Item 10. Directors, Executive Officers and Corporate Governance138
Item 11. Executive Compensation138
Item 12. Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters138
Item 13. Certain Relationships and Related Transactions, and Director Independence138
Item 14. Principal Accounting Fees and Services138
Part IV139
Item 15. Exhibits, Financial Statement Schedules139
Signatures142
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.